Letter from the editor.
Senior Vice President R&D and Chief Technology Officer; NasVax, Ltd.; Ness Ziona, Israel.
Ronald
R
Ellis
Acquisitions Editor; Landes Bioscience; Vienna, Austria.
Eva M
EM
Riedmann
D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology*; D019496:Cancer Vaccines / Q000008:administration & dosage / Q000276:immunology*; D035081:Editorial Policies; D006801:Humans; D007167:Immunotherapy / Q000379:methods* / Q000639:trends; D010506:Periodicals as Topic; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*
D001428:Bacterial Vaccines; D019496:Cancer Vaccines; D014765:Viral Vaccines